Navigation Links
Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
Date:9/18/2008

enior management plans to take a trip to the U.S. to meet with investors in New York, San Francisco and Southern California. This trip is what we hope will be the first of many visits to give U.S. shareholders a chance to meet with management and learn more about Yongye. If you would like to learn more about opportunities to meet face to face with Yongye's management, please do not hesitate to contact us directly at +86-8232-8866 Ext 8880, or our outside investor relations firm, CCG Investor Relations at +1-646-213-1915.

I hope this letter will give you a sense of our Yongye's development and our strategic direction. We look forward to updating you on events through earnings conference calls, press releases, our filings with the Securities and Exchange Commission and visits to meet with investors and the financial community. I would like to thank our customers, shareholders, directors and employees for the Company's present and future success.
Thank you for your interest in Yongye.

Mr. Zishen Wu

CEO and Chairman of the Board

Yongye Biotechnology International, Inc.

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development, distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

Forward Looking Statements

Certain statements set forth in this press release constitute "Forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... HAMBURG, Germany, December 16 Eppendorf ... Verigene(R) and Verigene(R) SP systems for,infringement of ... titled "Method for the,identification and/or the quantification ... any and all imports of the respective ... Customs authorities are required to confiscate any,violating ...
(Date:12/16/2009)... Separations Society will hold its 23rd Annual Technical Conference & Exhibition ... Antonio, Texas. To further impact the separation society and reach out ... announce that the 2010 AFS Annual Technical Conference will be co-located ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- The American Filtration ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... a global,provider of pharmaceutical competitive intelligence and market ... insight for pharma,and biotech companies with a stake ... Biogen/Elan,s Tysabri has been under scrutiny due to ... potentially fatal brain disease,associated with use of the ...
... Lead Arpida,s North-American Commercial Operations, REINACH, Switzerland, August ... results for the six months ending,30 June 2008., ... pipeline progress:, - Regulatory filings for intravenous iclaprim ... - Enrolment in Phase II "intravenous-to-oral" switch trial with ...
... at the University of Pennsylvania have theorized a way ... bound across chains of tiny metal particles to well ... shape. Application of this theory would use nanosized ... optical devices, which would operate at higher frequencies than ...
Other Biology Technology:Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri 2Arpida Reports Interim Results for Six Months to 30 June 2008 2University of Pennsylvania scientists move optical computing closer to reality 2University of Pennsylvania scientists move optical computing closer to reality 3
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
(Date:12/14/2009)... can be transmitted by sneezing, touching, or for ... a habit that may have driven the dinosaurs to ... Jacqueline Upcroft, a member of f1000 Biology, highlights the ... in PLoS One. This led them to deduce that ... jaw bones seen in many tyrannosaurid fossils. , The ...
(Date:12/14/2009)... from the Astrobiology Centre (INTA-CSIC) has shown that hydrogen ... formation of the most basic biological molecules can be ... carry out this study, published in the journal ... conditions of the early Earth. , "We have shown ... it produces hydrogen cyanide, a substance that could have ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Pacific Biometrics Completes 244 Million Debt Financing 10024 1Pacific Biometrics Completes 244 Million Debt Financing 10024 2Pacific Biometrics Completes 244 Million Debt Financing 10024 3Pacific Biometrics Completes 244 Million Debt Financing 10024 4Pacific Biometrics Completes 244 Million Debt Financing 10024 5Reportlinker Adds World Dynamic Signature Verification Market Report 10021 1Reportlinker Adds World Dynamic Signature Verification Market Report 10021 2Reportlinker Adds World Dynamic Signature Verification Market Report 10021 3Reportlinker Adds World Dynamic Signature Verification Market Report 10021 4Reportlinker Adds World Dynamic Signature Verification Market Report 10021 5Reportlinker Adds World Dynamic Signature Verification Market Report 10021 6Reportlinker Adds World Dynamic Signature Verification Market Report 10021 7Reportlinker Adds World Dynamic Signature Verification Market Report 10021 8Reportlinker Adds World Dynamic Signature Verification Market Report 10021 9BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 1BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 2BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 3BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 4
... drug addiction, neurodegenerative diseases, epilepsy, immune system defects, ... fruit fly (Drosophila melanogaster) is providing an excellent ... others. More than 5,000 researchers worldwide are currently ... will have beneficial effects for health; Spain is ...
... finasteride, taken by millions of balding men, artificially lowers ... standard screening test for prostate cancer, a multicenter study ... ranging in age from 40 to 60 years old, ... Lancet and is scheduled to be published after Jan. ...
... Rutgers researchers have discovered that the Chlamydia bacterium, which ... heritage with plants. That shared evolutionary heritage, which is ... prime target for development of an effective cure for ... bacterium and plants had been proposed by others," said ...
Other Biology News:A valuable fly for research into disease 2Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds 2Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia 2Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia 3
...
...
Use as the souce of CETP enzyme for screening CETP inhibitors. Use in conjunction with the CETP activity assay kit (K601-100)....
... The Zero Background Cloning Kit includes the ... in E. coli. The pZErO-1 vector utilizes ... small size of the Zeocin resistance gene ... ligation and transformation efficiencies. The kit contains ...
Biology Products: